Lupin is among the leading pharmaceutical companies with core focus on the brand building and market place. It’s focused on New Drug Delivery Systems (NDDS) and niche opportunities so as to provide superior compliance. Lupin Ltd. was founded on 31st March 1983 as a private ltd. company.
Its product portfolio includes anti-tuberculosis, cephalosporins, anti-asthma, cardiovascular, and non-steroid anti-inflammatory drugs. Lupin has 9 USFDA- approved manufacturing facilities. The Lupin research park (India) has about 160 scientists. Currently, the company is setting up a project for the manufacturing of 93 Tissue Plasminogen Activators (TPA) of Rifampicin, which is an essential anti-tuberculosis, anti-leprotic, life saving drug from a very basic stage of fermentation.
The Lupin Human Welfare and Research Foundation (LHWRF), which is committed to rural reconstruction, reaches out to over 1919 villages in eleven districts of four states covering
nearly 1.45 million people in India.
The Board of Directors is composed of the following members:
Dr Desh Bandhu Gupta, Chairman
Dr Kamal K Sharma, Managing Director
M. D. Gupta, Executive Director
Vinita Gupta, Director
Dr. K. U. Mada, Director
D. K. Contractor, Director
Marc Desaedeleer, Director
Sunil Nair, Director
Dr. Vijay Kelkar, Director
R. A. Shah, Director
Edward R. Roberts, Additional Director
Lupin has chosen quality, capacity and cost leadership as the basis of its Active Pharmaceuticals Ingredients (APIs) business. Apart from APIs, Lupin also manufactures and markets API advance penultimates.
Lupin has integrated Ayurveda and advanced techniques of modern science to manufacture an effective range of herbal drugs in the therapeutic areas of Pediatrics, GI, Pain management, gastro intestinal, diabetes and gynecology.
R&D at Lupin focuses on these three areas:
- Using the synthetic and herbal routes for New Chemical Entities (NCE)
- Generics Drug Master Files (DMFs) for APIs and Abbreviated New Drug Applications (ANDAs) for finished products
- New Drug Delivery Systems (NDDS)
- Anti-bacterial/fungal creams
- Iron preparations
Corporate Head Office Address
159 CST Road
Kalina, Santacruz (E)
Mumbai 400 098
Telephone +91-22 66402222
Fax +91-22 66402299
Web site: www.lupinworld.com
Recent Updated News of the Company
- Generics Drug Maker Biocom bought by Lupin
Lupin has bought the Russian drug maker ZAO Biocom to spread his wings in Russia. Lupin had aquired 100% stake in ZAO Biocom. It was recorded of RUB 786 billion in sales.